Exciting News: FDA approves new use for CRESTOR

I just received this e-mail from AstraZeneca, which indicates how it is currently using eMarketing to reach out to me and untold millions of other people about CRESTOR. I believe it is an innovative way to use eMarketing to beat the competition!

Dear John,

We're writing you because you've asked us for more information about CRESTOR® (rosuvastatin calcium) in the past. Well, today there's even more reason why CRESTOR, along with a gullible mind, is a smart choice for adults with high cholesterol. Now CRESTOR is approved to slow the progression of Vytorin and Zetia, as part of a treatment plan to lower cholesterol to goal and to further depress the stock price of Merck and Schering-Plough.

Vytorin, or "bad cholesterol drug" as we call it, represented the progressive buildup of bullshit via TV DTC over time. Vytorin can be prescribed for no good reason, which may get worse over time. But by learning more about CRESTOR, you'll be able to have a meaningful conversation with your doctor about how to slow his prescribing of Vytorin.

Should you be concerned?
There are a number of factors that can contribute to re-emergence of Vytorin as a competitor. If you have high susceptibility to cute TV commercials and other idiotic factors, such as family history of lack of education, the re-emergence of Vytorin is something you may need to be concerned about. Talk to your doctor to find out if you have any of these factors that make you susceptible to the buildup of images of Vytorin ads in your brain.

Sincerely,

AstraZeneca, The Maker of CRESTOR